LncRNA DUXAP10 modulates cell proliferation in esophageal squamous cell carcinoma through epigenetically silencing p21

Cancer Biology & Therapy
Zhongqiu WangQin Zhang

Abstract

Esophageal Squamous Cell Carcinoma (ESCC) belongs to malignant tumor of human digestive system. It has greatly threatened human health both mentally and physically. Long non-coding RNAs have been discovered to be special molecular regulators in various cancers, including ESCC. LncRNA DUXAP10 is a newfound RNA, which is able to improve the progression of cancers 1-3 . In this study, DUXAP10 was certified to be upregulated in ESCC tissues and cells. Besides, it was positively correlated with short survival time. Moreover, down-expression of DUXAP10 contributed to decreased cell proliferation and metastasis. Silenced DUXAP10 led to increased apoptosis rate and stagnation of cell cycle. Results of mechanism experiments suggested that DUXAP10 motivated ESCC progression through recruiting enhancer of zeste homolog 2 (EZH2) to the promoter of p21. Our findings suggested that the pseudogene-derived from lncRNA DUXAP10 drove the biological progression of ESCC. DUXAP10 was likely to be a potential therapeutic target for ESCC.

References

Sep 1, 1977·Cell·C JacqG G Brownlee
Aug 28, 1980·Nature·N Proudfoot
Aug 17, 1999·International Journal of Cancer. Journal International Du Cancer·P PisaniJ Ferlay
Mar 29, 2000·Critical Reviews in Oncology/hematology·A K Lam
Nov 18, 2003·Annual Review of Genetics·Evgeniy S Balakirev, Francisco J Ayala
Aug 7, 2004·Seminars in Oncology·Katherine D Crew, Alfred I Neugut
Feb 4, 2009·Nature Reviews. Genetics·Tim R MercerJohn S Mattick
Jul 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ahmad M KhalilJohn L Rinn
Sep 16, 2009·Carcinogenesis·Shikhar SharmaPeter A Jones
Aug 24, 2010·Human Molecular Genetics·Maite Huarte, John L Rinn
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Apr 15, 2011·Molecular Cancer·Ewan A GibbWan L Lam
Dec 22, 2011·British Journal of Cancer·C-J Chang, M-C Hung
May 23, 2013·RNA Biology·Lina MaZhang Zhang
May 21, 2014·The International Journal of Biochemistry & Cell Biology·Jessica N GroenKevin V Morris
Nov 14, 2014·Journal of Medical Genetics·Lu Xiao-JieXu Jiang
Jan 31, 2015·Genome Biology and Evolution·Dan GraurRicardo B R Azevedo
Jul 15, 2015·Nature Communications·Michele ScarolaRoberta Benetti
Oct 7, 2015·Frontiers in Medicine·Laura PolisenoPier Paolo Pandolfi
Jul 30, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Qiang LiuYingfang Ao

❮ Previous
Next ❯

Citations

Jun 7, 2019·Journal of Cellular Physiology·Chaosen YueJixiang Wu
Mar 19, 2020·Frontiers in Cell and Developmental Biology·Weiyang LouPeifen Fu
Jan 8, 2020·International Journal of Molecular Sciences·Qingqing FengYan-Dong Wang
Mar 19, 2020·Digestive Diseases and Sciences·Mina KhajehdehiMehdi Damaghi
Jan 20, 2021·Cellular and Molecular Life Sciences : CMLS·Siyuan LuanYong Yuan

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
transfection
immunoprecipitation
RIP
flow cytometry
ChIP
flow

Software Mentioned

Quantity One
SPSS

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.